Shield Therapeutics Statistics

Total Valuation

AIM:STX has a market cap or net worth of GBP 94.56 million. The enterprise value is 108.31 million.

Market Cap	94.56M
Enterprise Value	108.31M

Important Dates

The next estimated earnings date is Thursday, June 4, 2026.

Earnings Date	Jun 4, 2026
Ex-Dividend Date	n/a

Share Statistics

AIM:STX has 1.07 billion shares outstanding. The number of shares has increased by 12.77% in one year.

Current Share Class	1.07B
Shares Outstanding	1.07B
Shares Change (YoY)	+12.77%
Shares Change (QoQ)	-30.52%
Owned by Insiders (%)	1.70%
Owned by Institutions (%)	32.52%
Float	411.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.56
PB Ratio	-8.44
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.26
EV / Sales	2.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-42.82

Financial Position

The company has a current ratio of 0.90

Current Ratio	0.90
Quick Ratio	0.72
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-8.85
Interest Coverage	-1.35

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-10.24%
Return on Invested Capital (ROIC)	-31.32%
Return on Capital Employed (ROCE)	-66.74%
Weighted Average Cost of Capital (WACC)	15.67%
Revenue Per Employee	586,156
Profits Per Employee	-208,217
Employee Count	63
Asset Turnover	0.81
Inventory Turnover	3.58

Taxes

In the past 12 months, AIM:STX has paid 381,902 in taxes.

Income Tax	381,902
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +270.21% in the last 52 weeks. The beta is 1.91, so AIM:STX's price volatility has been higher than the market average.

Beta (5Y)	1.91
52-Week Price Change	+270.21%
50-Day Moving Average	8.95
200-Day Moving Average	8.34
Relative Strength Index (RSI)	47.58
Average Volume (20 Days)	2,220,688

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:STX had revenue of GBP 36.93 million and -13.12 million in losses. Loss per share was -0.01.

Revenue	36.93M
Gross Profit	17.12M
Operating Income	-7.47M
Pretax Income	-12.74M
Net Income	-13.12M
EBITDA	-6.64M
EBIT	-7.47M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 8.63 million in cash and 22.39 million in debt, giving a net cash position of -13.76 million or -0.01 per share.

Cash & Cash Equivalents	8.63M
Total Debt	22.39M
Net Cash	-13.76M
Net Cash Per Share	-0.01
Equity (Book Value)	-11.20M
Book Value Per Share	-0.02
Working Capital	-3.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.51 million and capital expenditures -17,832, giving a free cash flow of -2.53 million.

Operating Cash Flow	-2.51M
Capital Expenditures	-17,832
Depreciation & Amortization	824,908
Net Borrowing	1.12M
Free Cash Flow	-2.53M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 46.36%, with operating and profit margins of -20.22% and -35.52%.

Gross Margin	46.36%
Operating Margin	-20.22%
Pretax Margin	-34.49%
Profit Margin	-35.52%
EBITDA Margin	-17.98%
EBIT Margin	-20.22%
FCF Margin	n/a

Dividends & Yields

AIM:STX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.77%
Shareholder Yield	-12.77%
Earnings Yield	-13.87%
FCF Yield	-2.67%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:STX has an Altman Z-Score of -5.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.27
Piotroski F-Score	3